LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are

European Journal of Neurology

Volumn 6, Issue 6, 1999, Pages 691-696

  Frikke Schmidt, Ruth ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cerebrovascular disorders; Cholesterol; Mutations; Risk factors

Indexed keywords

ADENOSINE; APOLIPOPROTEIN B; ARGININE; CHOLESTEROL; CYSTEINE; GLUTAMINE; GUANOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SERINE; TRYPTOPHAN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032804634     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.660691.x     Document Type: Article

References (2)

1. Agerholm-Larsen B, Tybjærg-Hansen A, Frikke-Schmidt R, Grønholdt MLM, Jensen G, Nordestgaard BG (1997). ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med 127:346-355.
2. Appleyard M, Hansen AT, Jensen G, Schnohr P, Nyboe J (1989). The Copenhagen City Heart Study. Østerbrounder søgelsen. A book of tables with data from the first examination (1976-78) and a five-year follow-up (1981-83). Scand J Social Med Suppl 41:1-160.